8-K Announcements
6Material company update
Apr 22, 2026·SEC
Material company update
Feb 3, 2026·SEC
Material company update
Jan 28, 2026·SEC
Lam Research Corporation(LRCX)Earnings, Financials & Key Ratios
LRCX•NASDAQ
93.7× P/E·Price updated Jun 19, 2026
AboutLam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products. It also provides SPEED gapfill high-density plasma chemical vapor deposition products; and Striker single-wafer atomic layer deposition products for dielectric film solutions. In addition, the company offers Flex for dielectric etch applications; Kiyo for conductor etch applications; Syndion for through-silicon via etch applications; and Versys metal products for metal etch processes. Further, it provides Coronus bevel clean products to enhance die yield; Da Vinci, DV-Prime, EOS, and SP series products to address various wafer cleaning applications; and Metryx mass metrology systems for high precision in-line mass measurement in semiconductor wafer manufacturing. The company sells its products and services to semiconductors industry in the United States, China, Europe, Japan, Korea, Southeast Asia, Taiwan, and internationally. Lam Research Corporation was incorporated in 1980 and is headquartered in Fremont, California.Show more
- Revenue$18.44B+23.7%
- EBITDA$6.29B+36.0%
- Net Income$5.36B+40.0%
- EPS (Diluted)4.15+43.1%
- Gross Margin48.7%+2.9%
- EBITDA Margin34.1%+9.9%
- Operating Margin32.01%+11.9%
- Net Margin29.06%+13.2%
- ROE58.24%+27.4%
LRCX Key Insights
Lam Research Corporation (LRCX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Excellent 3Y average ROE of 55.4%
- ✓Strong 5Y profit CAGR of 18.9%
- ✓Strong Piotroski F-Score: 8/9
- ✓FCF machine: 29.4% free cash flow margin
- ✓12 consecutive years of dividend growth
- ✓Momentum leader: RS Rating 96 (top 4%)
✗Weaknesses
- ✗Expensive at 50.9x book value
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when LRCX posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
LRCX Price & Volume
Lam Research Corporation (LRCX) stock price & volume — 10-year historical chart
Loading chart...
LRCX Growth Metrics
Lam Research Corporation (LRCX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years13.36%
5 Years12.91%
3 Years2.29%
TTM26.53%
Profit CAGR
10 Years23.38%
5 Years18.93%
3 Years5.18%
TTM44%
EPS CAGR
10 Years27.35%
5 Years22.41%
3 Years8.27%
TTM47.63%
Return on Capital
10 Years30.78%
5 Years37.73%
3 Years35.95%
Last Year40.44%
LRCX Recent Earnings
Lam Research Corporation (LRCX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 22, 2026Metric
Actual
Est
EPS
$1.47+8.1%
$1.36
Rev
$5.8B+1.6%
$5.8B
Q1 2026
Jan 28, 2026Metric
Actual
Est
EPS
$1.27+8.5%
$1.17
Rev
$5.3B+2.1%
$5.2B
Q4 2025
Oct 22, 2025Metric
Actual
Est
EPS
$1.26+3.3%
$1.22
Rev
$5.3B+1.9%
$5.2B
Q3 2025
Jul 30, 2025Metric
Actual
Est
EPS
$1.33+9.9%
$1.21
Rev
$5.2B+3.3%
$5.0B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 22, 2026 | $1.47vs $1.36+8.1% | $5.8Bvs $5.8B+1.6% |
| Q1 2026 | Jan 28, 2026 | $1.27vs $1.17+8.5% | $5.3Bvs $5.2B+2.1% |
| Q4 2025 | Oct 22, 2025 | $1.26vs $1.22+3.3% | $5.3Bvs $5.2B+1.9% |
| Q3 2025 | Jul 30, 2025 | $1.33vs $1.21+9.9% | $5.2Bvs $5.0B+3.3% |
Based on last 12 quarters of dataView full earnings history →
LRCX Peer Comparison
Lam Research Corporation (LRCX) competitors in Semiconductor Manufacturing Equipment — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 AMAT | 489.96B | 617.11 | 71.26 | 4.39% | 29.31% | 39.78% | 0.35 | |
 KLAC | 34.2B | 259.56 | 8.55 | 23.89% | 35.66% | 89.07% | 1.30 | |
 ASML | 749B | 1929.68 | 70.65 | 11.02% | 29.42% | 47.08% | 0.14 | |
 TER | 68.56B | 437.92 | 125.84 | 13.13% | 22.55% | 29.72% | 0.12 | |
 ONTO | 16.6B | 333.76 | 120.06 | 1.82% | 10.33% | 5.19% | 0.01 | |
 ACLS | 5.76B | 187.53 | 49.35 | -17.57% | 11.93% | 9.79% | 0.04 | |
 NVMI | 18.29B | 575.31 | 72.28 | 30.96% | 29.21% | 21.21% | 0.65 | |
 CAMT | 8.94B | 195.16 | 187.65 | 15.57% | 28.36% | 23.49% | 0.84 |
Compare LRCX vs Peers
Lam Research Corporation (LRCX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
LRCX Income Statement
Lam Research Corporation (LRCX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 8.01B | 11.08B | 9.65B | 10.04B | 14.63B | 17.23B | 17.43B | 14.91B | 18.44B | 21.68B |
Revenue Growth % | 36.15% | 38.23% | -12.85% | 4.05% | 45.61% | 17.78% | 1.16% | -14.47% | 23.68% | 26.53% |
Cost of Goods Sold | 4.41B | 5.91B | 5.3B | 5.44B | 7.82B | 9.36B | 9.65B | 7.85B | 9.46B | 10.85B |
COGS % of Revenue | 55.03% | 53.37% | 54.85% | 54.12% | 53.47% | 54.31% | 55.38% | 52.68% | 51.3% | - |
Gross Profit | 3.6B▲ 0% | 5.17B▲ 43.3% | 4.36B▼ 15.6% | 4.61B▲ 5.7% | 6.81B▲ 47.7% | 7.87B▲ 15.7% | 7.78B▼ 1.2% | 7.05B▼ 9.3% | 8.98B▲ 27.3% | 10.84B▲ 0% |
Gross Margin % | 44.97% | 46.63% | 45.15% | 45.88% | 46.53% | 45.69% | 44.63% | 47.32% | 48.7% | 49.98% |
Gross Profit Growth % | 37.59% | 43.34% | -15.62% | 5.74% | 47.66% | 15.67% | -1.21% | -9.31% | 27.31% | - |
Operating Expenses | 1.7B | 1.95B | 1.89B | 1.93B | 2.32B | 2.49B | 2.6B | 2.79B | 3.08B | 3.41B |
OpEx % of Revenue | 21.23% | 17.62% | 19.62% | 19.26% | 15.88% | 14.45% | 14.93% | 18.71% | 16.7% | - |
Selling, General & Admin | 667.49M | 762.22M | 702.41M | 682.48M | 829.88M | 885.74M | 832.75M | 868.25M | 981.7M | 1.1B |
SG&A % of Revenue | 8.33% | 6.88% | 7.28% | 6.79% | 5.67% | 5.14% | 4.78% | 5.83% | 5.33% | - |
Research & Development | 1.03B | 1.19B | 1.19B | 1.25B | 1.49B | 1.6B | 1.73B | 1.9B | 2.1B | 2.31B |
R&D % of Revenue | 12.9% | 10.74% | 12.34% | 12.47% | 10.21% | 9.31% | 9.91% | 12.76% | 11.37% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 42.15M | 18.19M | 0 | 0 |
Operating Income | 1.9B▲ 0% | 3.21B▲ 68.9% | 2.46B▼ 23.3% | 2.67B▲ 8.5% | 4.48B▲ 67.6% | 5.38B▲ 20.1% | 5.17B▼ 3.8% | 4.26B▼ 17.6% | 5.9B▲ 38.4% | 7.43B▲ 0% |
Operating Margin % | 23.74% | 29.01% | 25.53% | 26.62% | 30.64% | 31.24% | 29.7% | 28.61% | 32.01% | 34.26% |
Operating Income Growth % | 77.07% | 68.93% | -23.3% | 8.48% | 67.63% | 20.08% | -3.85% | -17.6% | 38.39% | - |
EBITDA | 2.21B | 3.54B | 2.77B | 2.94B | 4.79B | 5.72B | 5.52B | 4.62B | 6.29B | 7.85B |
EBITDA Margin % | 27.57% | 31.96% | 28.74% | 29.29% | 32.74% | 33.18% | 31.66% | 31.02% | 34.1% | 36.2% |
EBITDA Growth % | 61.8% | 60.24% | -21.63% | 6.07% | 62.77% | 19.34% | -3.47% | -16.2% | 35.98% | 38.59% |
D&A (Non-Cash Add-back) | 306.9M | 326.39M | 309.28M | 268.52M | 307.15M | 333.74M | 342.43M | 359.7M | 386.28M | 420.33M |
EBIT | 1.93B | 3.25B | 2.56B | 2.75B | 4.58B | 5.38B | 5.3B | 4.55B | 5.96B | 7.56B |
Net Interest Income | -59.88M | -11.57M | -18.49M | -92.01M | -188.91M | -169.55M | -47.48M | 66.7M | 53.13M | 54.1M |
Interest Income | 57.86M | 85.81M | 98.77M | 85.43M | 19.69M | 15.21M | 138.98M | 251.94M | 231.33M | 182.49M |
Interest Expense | 117.73M | 97.39M | 117.26M | 177.44M | 208.6M | 184.76M | 186.46M | 185.24M | 178.2M | 128.39M |
Other Income/Expense | -90.46M | -61.51M | -18.16M | -98.82M | -111.22M | -188.71M | -65.65M | 96.31M | 57.16M | 58.88M |
Pretax Income | 1.81B▲ 0% | 3.15B▲ 74.0% | 2.45B▼ 22.4% | 2.57B▲ 5.2% | 4.37B▲ 69.7% | 5.19B▲ 18.8% | 5.11B▼ 1.6% | 4.36B▼ 14.7% | 5.96B▲ 36.6% | 7.49B▲ 0% |
Pretax Margin % | 22.61% | 28.45% | 25.34% | 25.64% | 29.88% | 30.15% | 29.32% | 29.25% | 32.32% | 34.53% |
Income Tax | 113.91M | 771.11M | 255.14M | 323.23M | 462.35M | 587.83M | 598.28M | 532.45M | 599.91M | 778.11M |
Effective Tax Rate % | 6.29% | 24.47% | 10.43% | 12.55% | 10.58% | 11.32% | 11.71% | 12.21% | 10.07% | 10.39% |
Net Income | 1.7B▲ 0% | 2.38B▲ 40.2% | 2.19B▼ 7.9% | 2.25B▲ 2.8% | 3.91B▲ 73.6% | 4.61B▲ 17.8% | 4.51B▼ 2.0% | 3.83B▼ 15.1% | 5.36B▲ 40.0% | 6.71B▲ 0% |
Net Margin % | 21.19% | 21.49% | 22.7% | 22.42% | 26.72% | 26.73% | 25.89% | 25.68% | 29.06% | 30.94% |
Net Income Growth % | 85.74% | 40.22% | -7.95% | 2.75% | 73.57% | 17.83% | -2.05% | -15.14% | 39.98% | 44% |
Net Income (Continuing) | 1.7B | 2.38B | 2.19B | 2.25B | 3.91B | 4.61B | 4.51B | 3.83B | 5.36B | 6.71B |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.92▲ 0% | 1.32▲ 43.5% | 1.37▲ 3.8% | 1.51▲ 10.2% | 2.69▲ 78.1% | 3.27▲ 21.6% | 3.32▲ 1.5% | 2.90▼ 12.7% | 4.15▲ 43.1% | 5.34▲ 0% |
EPS Growth % | 76.92% | 43.48% | 3.79% | 10.22% | 78.15% | 21.56% | 1.53% | -12.65% | 43.1% | 47.63% |
EPS (Basic) | 1.05 | 1.47 | 1.44 | 1.56 | 2.72 | 3.29 | 3.33 | 2.91 | 4.17 | - |
Diluted Shares Outstanding | 1.84B | 1.81B | 1.6B | 1.49B | 1.45B | 1.41B | 1.36B | 1.32B | 1.29B | 1.26B |
Basic Shares Outstanding | 1.62B | 1.81B | 1.52B | 1.45B | 1.44B | 1.4B | 1.35B | 1.31B | 1.29B | 1.25B |
Dividend Payout Ratio | 14.34% | 12.92% | 30.95% | 29.17% | 18.6% | 17.7% | 20.13% | 26.62% | 21.45% | - |
LRCX Balance Sheet
Lam Research Corporation (LRCX) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 9.14B | 9.15B | 8.56B | 10.85B | 11.65B | 12.29B | 13.23B | 12.88B | 14.52B | 13.3B |
Cash & Short-Term Investments | 6.04B | 4.95B | 5.43B | 6.71B | 5.73B | 3.66B | 5.37B | 5.85B | 6.39B | 4.75B |
Cash Only | 2.38B | 4.51B | 3.66B | 4.92B | 4.42B | 3.52B | 5.34B | 5.85B | 6.39B | 4.75B |
Short-Term Investments | 3.66B | 437.34M | 1.77B | 1.8B | 1.31B | 135.73M | 37.64M | 0 | 0 | 0 |
Accounts Receivable | 1.67B | 2.18B | 1.46B | 2.1B | 3.03B | 4.31B | 2.82B | 2.52B | 3.38B | 4.13B |
Days Sales Outstanding | 76.22 | 71.73 | 55.03 | 76.2 | 75.53 | 91.4 | 59.14 | 61.69 | 66.88 | 61.6 |
Inventory | 1.23B | 1.88B | 1.54B | 1.9B | 2.69B | 3.97B | 4.82B | 4.22B | 4.31B | 4B |
Days Inventory Outstanding | 102.04 | 115.83 | 106.16 | 127.58 | 125.51 | 154.75 | 182.14 | 196.06 | 166.28 | 138.33 |
Other Current Assets | 8.27M | 7.69M | 1.37M | 0 | 0 | 0 | -37.64M | 298.19M | 440.27M | 0 |
Total Non-Current Assets | 2.98B | 3.33B | 3.44B | 3.71B | 4.24B | 4.91B | 5.55B | 5.86B | 6.83B | 7.49B |
Property, Plant & Equipment | 685.6M | 902.55M | 1.06B | 1.25B | 1.48B | 1.65B | 1.86B | 2.15B | 2.43B | 2.85B |
Fixed Asset Turnover | 11.69x | 12.27x | 9.12x | 8.06x | 9.90x | 10.46x | 9.39x | 6.92x | 7.59x | 8.26x |
Goodwill | 1.39B | 1.48B | 1.48B | 1.48B | 1.49B | 1.52B | 1.62B | 1.63B | 1.63B | 0 |
Intangible Assets | 411M | 317.84M | 216.95M | 168.53M | 132.37M | 101.85M | 168.45M | 138.54M | 182.2M | 1.88B |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.95M | 17M | 35.83M |
Other Non-Current Assets | 754.21M | 880.58M | 937.01M | 806.46M | 1.14B | 1.65B | 1.91B | 1.94B | 2.57B | 2.76B |
Total Assets | 12.12B▲ 0% | 12.48B▲ 2.9% | 12B▼ 3.8% | 14.56B▲ 21.3% | 15.89B▲ 9.2% | 17.2B▲ 8.2% | 18.78B▲ 9.2% | 18.74B▼ 0.2% | 21.35B▲ 13.9% | 20.79B▲ 0% |
Asset Turnover | 0.66x | 0.89x | 0.80x | 0.69x | 0.92x | 1.00x | 0.93x | 0.80x | 0.86x | 1.02x |
Asset Growth % | -1.21% | 2.94% | -3.83% | 21.31% | 9.16% | 8.2% | 9.22% | -0.2% | 13.87% | 37.94% |
Total Current Liabilities | 2.95B | 3.15B | 2.37B | 3.16B | 3.53B | 4.56B | 4.18B | 4.34B | 6.57B | 5.24B |
Accounts Payable | 464.64M | 510.98M | 376.56M | 592.39M | 829.71M | 1.01B | 470.7M | 613.97M | 854.21M | 0 |
Days Payables Outstanding | 38.45 | 31.55 | 25.96 | 39.78 | 38.72 | 39.45 | 17.8 | 28.54 | 32.97 | 23.09 |
Short-Term Debt | 908.44M | 610.03M | 667.13M | 836.11M | 0 | 0 | 421K | 501.32M | 749.67M | 4.09M |
Deferred Revenue (Current) | 607.67M | 720.09M | 381.32M | 457.52M | 967.33M | 1.57B | 1.7B | 1.42B | 2.57B | 5.21B |
Other Current Liabilities | 609.34M | 698.95M | 464.02M | 520.24M | 728.96M | 1.3B | 1.32B | 1.35B | 1.48B | 5.24B |
Current Ratio | 3.10x | 2.90x | 3.61x | 3.43x | 3.30x | 2.69x | 3.16x | 2.97x | 2.21x | 2.54x |
Quick Ratio | 2.68x | 2.31x | 2.96x | 2.83x | 2.54x | 1.82x | 2.01x | 2.00x | 1.55x | 1.77x |
Cash Conversion Cycle | 139.8 | 156.02 | 135.24 | 164 | 162.31 | 206.69 | 223.47 | 229.21 | 200.19 | 176.83 |
Total Non-Current Liabilities | 2.19B | 2.75B | 4.91B | 6.21B | 6.34B | 6.35B | 6.39B | 5.87B | 4.92B | 4.96B |
Long-Term Debt | 1.78B | 1.81B | 3.82B | 4.96B | 4.95B | 4.96B | 4.96B | 4.47B | 3.72B | 3.73B |
Capital Lease Obligations | 0 | 0 | 0 | 11.48M | 29.4M | 35.99M | 38.24M | 12.47M | 203.84M | 10.5M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 400.36M | 942.57M | 1.08B | 1.24B | 1.35B | 1.35B | 1.38B | 1.39B | 991.68M | 1.23B |
Total Liabilities | 5.14B | 5.9B | 7.28B | 9.38B | 9.86B | 10.92B | 10.57B | 10.21B | 11.48B | 10.21B |
Total Debt | 2.69B | 2.42B | 4.49B | 5.81B | 5B | 5.01B | 5.01B | 4.98B | 4.76B | 3.73B |
Net Debt | 315.88M | -2.1B | 831.68M | 895.55M | 576.8M | 1.48B | -325.51M | -864.52M | -1.63B | -1.02B |
Debt / Equity | 0.39x | 0.37x | 0.95x | 1.12x | 0.83x | 0.80x | 0.61x | 0.58x | 0.48x | 0.35x |
Debt / EBITDA | 1.22x | 0.68x | 1.62x | 1.97x | 1.04x | 0.88x | 0.91x | 1.08x | 0.76x | 0.48x |
Net Debt / EBITDA | 0.14x | -0.59x | 0.30x | 0.30x | 0.12x | 0.26x | -0.06x | -0.19x | -0.26x | -0.13x |
Interest Coverage | 16.39x | 33.36x | 21.86x | 15.51x | 21.95x | 29.11x | 28.40x | 24.54x | 33.43x | 58.92x |
Total Equity | 6.99B▲ 0% | 6.58B▼ 5.8% | 4.72B▼ 28.2% | 5.18B▲ 9.7% | 6.03B▲ 16.3% | 6.28B▲ 4.2% | 8.21B▲ 30.8% | 8.54B▲ 4.0% | 9.86B▲ 15.5% | 10.58B▲ 0% |
Equity Growth % | 14.51% | -5.83% | -28.22% | 9.74% | 16.28% | 4.17% | 30.77% | 4.01% | 15.48% | 62.27% |
Book Value per Share | 3.80 | 3.64 | 2.95 | 3.48 | 4.15 | 4.46 | 6.04 | 6.47 | 7.64 | 8.42 |
Total Shareholders' Equity | 6.99B | 6.58B | 4.72B | 5.18B | 6.03B | 6.28B | 8.21B | 8.54B | 9.86B | 10.58B |
Common Stock | 162K | 157K | 144K | 145K | 143K | 137K | 133K | 130K | 1.27M | 1.25M |
Retained Earnings | 6.25B | 8.26B | 9.93B | 11.52B | 14.68B | 18.45B | 22.03B | 24.81B | 28.99B | 33B |
Treasury Stock | -5.22B | -7.85B | -11.6B | -12.95B | -15.65B | -19.48B | -21.53B | -24.37B | -27.76B | 0 |
Accumulated OCI | -61.7M | -57.45M | -64.03M | -94.21M | -64.13M | -109.98M | -100.71M | -130.43M | -62.42M | -121.39M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LRCX Cash Flow Statement
Lam Research Corporation (LRCX) cash flow — operating, investing & free cash flow history
| Metric | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 2.03B | 2.66B | 3.18B | 2.13B | 3.59B | 3.1B | 5.18B | 4.65B | 6.17B | 6.95B |
Operating CF Margin % | 25.32% | 23.98% | 32.9% | 21.17% | 24.53% | 17.99% | 29.72% | 31.21% | 33.49% | - |
Operating CF Growth % | 50.29% | 30.87% | 19.59% | -33.05% | 68.74% | -13.61% | 67.08% | -10.17% | 32.69% | 296.29% |
Net Income | 1.7B | 2.38B | 2.19B | 2.25B | 3.91B | 4.61B | 4.51B | 3.83B | 5.36B | 6.71B |
Depreciation & Amortization | 306.9M | 326.39M | 309.28M | 268.52M | 307.15M | 333.74M | 342.43M | 359.7M | 386.28M | 420.33M |
Stock-Based Compensation | 149.97M | 172.22M | 187.23M | 189.2M | 220.16M | 259.06M | 286.6M | 293.06M | 343.37M | 376.68M |
Deferred Taxes | 104.94M | 3.05M | -4.98M | -17.78M | -151.48M | -257.44M | -172.06M | -198.98M | -363.25M | -264.99M |
Other Non-Cash Items | 80.53M | 90.6M | 1.52M | 6.63M | -17.39M | -44.75M | 52.3M | 10.24M | 6.84M | -189.78M |
Working Capital Changes | -310.83M | -317.19M | 491.52M | -571.88M | -678.74M | -1.8B | 158.74M | 360.48M | 441.8M | -95.83M |
Change in Receivables | -411.29M | -501.63M | 732.14M | -641.83M | -928.93M | -1.29B | 1.45B | 303.44M | -858.75M | 0 |
Change in Inventory | -307.88M | -701.01M | 281.36M | -411.61M | -792.59M | -1.35B | -961.97M | 528.72M | -180.73M | 0 |
Change in Payables | 126.82M | 35.66M | -131.47M | 208.48M | 184.62M | 167.88M | -522.2M | 125.94M | 212M | 0 |
Cash from Investing | -2.06B | 2.75B | -1.64B | -244.08M | 73.27M | 612.27M | -534.56M | -370.61M | -708.09M | -907.66M |
Capital Expenditures | -157.42M | -273.47M | -303.49M | -203.24M | -349.1M | -546.03M | -501.57M | -396.67M | -759.19M | -503.8M |
CapEx % of Revenue | 1.96% | 2.47% | 3.14% | 2.02% | 2.39% | 3.17% | 2.88% | 2.66% | 4.12% | 2.32% |
Acquisitions | 157.42M | -115.7M | 303.49M | 203.24M | 349.1M | 0 | -119.95M | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -2.87B | 2.52B | -1.91B | -229.08M | -391.25M | -7.58M | 86.96M | -11.71M | 51.09M | -403.87M |
Cash from Financing | -2.63B | -3.27B | -2.39B | -623.93M | -4.17B | -4.58B | -2.83B | -4B | -4.94B | -6.75B |
Debt Issued (Net) | -1.69B | -396.09M | 2B | 1.31B | -862.06M | -11.89M | -23.21M | -256.1M | -507.49M | -755.56M |
Equity Issued (Net) | -739.1M | -2.64B | -3.77B | -1.37B | -2.67B | -3.86B | -2.01B | -2.83B | -3.28B | -4.74B |
Dividends Paid | -243.5M | -307.61M | -678.35M | -656.84M | -726.99M | -815.29M | -907.91M | -1.02B | -1.15B | -1.24B |
Share Repurchases | -811.67M | -2.65B | -3.78B | -1.37B | -2.7B | -3.87B | -2.02B | -2.84B | -3.42B | -4.9B |
Other Financing | 38.51M | 75.63M | 64.75M | 95.44M | 95.65M | 108.22M | 106.35M | 106.42M | 143K | -14.33M |
Net Change in Cash | -2.66B▲ 0% | 2.13B▲ 180.2% | -855.16M▼ 140.1% | 1.26B▲ 246.8% | -498.33M▼ 139.7% | -897.22M▼ 80.0% | 1.81B▲ 302.2% | 263.43M▼ 85.5% | 556.85M▲ 111.4% | -696.15M▲ 0% |
Free Cash Flow | 1.87B▲ 0% | 2.38B▲ 27.3% | 2.87B▲ 20.6% | 1.92B▼ 33.0% | 3.24B▲ 68.4% | 2.55B▼ 21.2% | 4.68B▲ 83.2% | 4.26B▼ 9.0% | 5.41B▲ 27.2% | 6.45B▲ 0% |
FCF Margin % | 23.36% | 21.51% | 29.76% | 19.15% | 22.15% | 14.82% | 26.84% | 28.55% | 29.37% | 29.75% |
FCF Growth % | 59.31% | 27.27% | 20.58% | -33.05% | 68.42% | -21.16% | 83.16% | -9.02% | 27.22% | 57.62% |
FCF per Share | 1.02 | 1.32 | 1.80 | 1.29 | 2.23 | 1.82 | 3.44 | 3.22 | 4.20 | 5.13 |
FCF Conversion (FCF/Net Income) | 1.20x | 1.12x | 1.45x | 0.94x | 0.92x | 0.67x | 1.15x | 1.22x | 1.15x | 0.96x |
Interest Paid | 104.62M | 84.4M | 76.93M | 171.89M | 203.93M | 175.53M | 174.75M | 173.09M | 172.35M | 0 |
Taxes Paid | 28.1M | 142.8M | 300.27M | 222.91M | 518.57M | 807.67M | 809.75M | 991.82M | 972.51M | 0 |
LRCX Key Ratios
Lam Research Corporation (LRCX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 25.94% | 35.09% | 38.77% | 45.46% | 69.73% | 74.85% | 62.27% | 45.71% | 58.24% | 65.79% |
Return on Invested Capital (ROIC) | 22.48% | 40.89% | 36.83% | 34.47% | 53.01% | 56.19% | 49.61% | 41.11% | 55.66% | 65.62% |
Gross Margin | 44.97% | 46.63% | 45.15% | 45.88% | 46.53% | 45.69% | 44.63% | 47.32% | 48.7% | 49.98% |
Net Margin | 21.19% | 21.49% | 22.7% | 22.42% | 26.72% | 26.73% | 25.89% | 25.68% | 29.06% | 30.94% |
Debt / Equity | 0.39x | 0.37x | 0.95x | 1.12x | 0.83x | 0.80x | 0.61x | 0.58x | 0.48x | 0.35x |
Interest Coverage | 16.39x | 33.36x | 21.86x | 15.51x | 21.95x | 29.11x | 28.40x | 24.54x | 33.43x | 58.92x |
FCF Conversion | 1.20x | 1.12x | 1.45x | 0.94x | 0.92x | 0.67x | 1.15x | 1.22x | 1.15x | 0.96x |
Revenue Growth | 36.15% | 38.23% | -12.85% | 4.05% | 45.61% | 17.78% | 1.16% | -14.47% | 23.68% | 26.53% |
Related:LRCX Dividend History·LRCX Revenue History·LRCX Price History·LRCX P/E History·LRCX Financial Ratios·LRCX Institutional Holders
LRCX SEC Filings & Documents
Lam Research Corporation (LRCX) SEC filings — annual & quarterly reports (10-K, 10-Q)
LRCX Frequently Asked Questions
Lam Research Corporation (LRCX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Lam Research Corporation (LRCX) reported $21.68B in revenue for fiscal year 2025. This represents a 1555% increase from $1.31B in 1996.
Lam Research Corporation (LRCX) grew revenue by 23.7% over the past year. This is strong growth.
Yes, Lam Research Corporation (LRCX) is profitable, generating $6.71B in net income for fiscal year 2025 (29.1% net margin).
Dividend & Returns
Yes, Lam Research Corporation (LRCX) pays a dividend with a yield of 0.23%. This makes it attractive for income-focused investors.
Lam Research Corporation (LRCX) has a return on equity (ROE) of 58.2%. This is excellent, indicating efficient use of shareholder capital.
Lam Research Corporation (LRCX) generated $6.45B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.